What to do about immune thrombocytopenia

Immune thrombocytopenia is an autoimmune disease in which a patient's immune system mistakenly attacks and destroys its own platelets, leading to a reduced platelet count and an increased tendency for bruising and bleeding. The treatment options for immune thrombocytopenia mainly include the following: 1. **Drug therapy**: Commonly used medications include glucocorticoids such as prednisone acetate and dexamethasone. These drugs reduce the production of platelet-related antibodies and decrease platelet destruction in the spleen. For patients who are dependent on or intolerant to steroids, newer medications such as TPO receptor agonists or immunosuppressants may be considered. 2. **Surgical treatment**: For some patients with severe disease, splenectomy is an effective treatment option, as the spleen is the primary site of platelet destruction. 3. **Other treatments**: These include the use of hematopoietic growth factors to increase platelet counts or administration of high-dose intravenous immunoglobulin in emergency bleeding situations. Additionally, for patients with chronic or refractory disease, rituximab is also a viable treatment option. If bleeding symptoms occur (such as persistent nosebleeds, gum bleeding, skin bruising, etc.), prompt medical attention should be sought.